Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy
- PMID: 32016016
- PMCID: PMC6976474
- DOI: 10.21037/atm.2019.11.11
Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969503 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources